These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37349865)

  • 1. Patient preferences for atopic dermatitis treatments: a discrete choice experiment.
    Kwatra SG; Lio P; Weidinger S; Calimlim B; Ladizinski B; Vigna N; Botha W; Mansfield C
    J Dermatolog Treat; 2023 Dec; 34(1):2222201. PubMed ID: 37349865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment.
    Boeri M; Sutphin J; Hauber B; Cappelleri JC; Romero W; Di Bonaventura M
    J Dermatolog Treat; 2022 May; 33(3):1449-1458. PubMed ID: 33023361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment.
    Thomas C; Raibouaa A; Wollenberg A; Capron JP; Krucien N; Karn H; Tervonen T
    BMJ Open; 2022 Aug; 12(8):e058799. PubMed ID: 35918108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment.
    Feldman SR; Guerin A; Gauthier-Loiselle M; Claxton AJ; Hazra NC; Meng Y; Gallant K; Balu S
    J Dermatolog Treat; 2024 Dec; 35(1):2345739. PubMed ID: 38705585
    [No Abstract]   [Full Text] [Related]  

  • 5. Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment.
    Feldman SR; Thyssen JP; Boeri M; Gerber R; Neary MP; Cha A; Hauber B; Cappelleri JC; Xenakis J; Leach C; Zeichner J
    J Dermatolog Treat; 2024 Dec; 35(1):2304020. PubMed ID: 38221777
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment preferences among patients with mild-to-moderate atopic dermatitis.
    Myers K; Silverberg JI; Parasuraman S; Pierce A; Eichenfield LF; Poulos C
    J Dermatolog Treat; 2023 Dec; 34(1):2215356. PubMed ID: 37259544
    [No Abstract]   [Full Text] [Related]  

  • 7. Patients' preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most.
    Schaarschmidt ML; Kromer D; Wellmann P; Peitsch WK; Kromer C
    J Dermatolog Treat; 2024 Dec; 35(1):2308682. PubMed ID: 38297480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
    Carrascosa Carrillo JM; Baselga Torres E; Gilaberte Calzada Y; Jurgens Martínez YN; Roustan Gullón G; Yanguas Bayona JI; Gómez Castro S; Ferrario MG; Rebollo Laserna FJ
    Dermatol Ther (Heidelb); 2022 May; 12(5):1197-1210. PubMed ID: 35445962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis.
    Ameen M; Alhusayen R; Brandi H; Bøgelund M; Jensen HH; Reitzel SB; Thyssen JP
    Acta Derm Venereol; 2024 Feb; 104():adv24339. PubMed ID: 38380974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial.
    Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C
    Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and physician preferences for atopic dermatitis injection treatments in Japan.
    Okubo Y; Ho KA; Fifer S; Fujita H; Oki Y; Taguchi Y
    J Dermatolog Treat; 2020 Dec; 31(8):821-830. PubMed ID: 31250681
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients.
    Torisu-Itakura H; Anderson P; Piercy J; Pike J; Sakamoto A; Kabashima K
    Curr Med Res Opin; 2022 Aug; 38(8):1401-1410. PubMed ID: 35787197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis.
    Eastman WJ; Malahias S; Delconte J; DiBenedetti D
    Cutis; 2014 Jul; 94(1):46-53. PubMed ID: 25101344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States.
    Feldman SR; Holmen Moeller A; Erntoft Idemyr ST; González JM
    J Health Econ Outcomes Res; 2017; 4(2):141-157. PubMed ID: 37661952
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
    Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
    Silverberg JI; DeLozier A; Sun L; Thyssen JP; Kim B; Yosipovitch G; Nunes FP; Gugiu PC; Doll HA; Eichenfield LF
    Health Qual Life Outcomes; 2021 Oct; 19(1):247. PubMed ID: 34688290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
    Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
    Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and Germany.
    Feldman SR; Poulos C; Gilloteau I; Mange B; Boehm K; Boeri M; Naatz M; Augustin M
    J Dermatolog Treat; 2022 May; 33(3):1511-1520. PubMed ID: 33535847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.